<VariationArchive VariationID="2076" VariationName="NM_020435.4(GJC2):c.914_947del (p.Pro305fs)" VariationType="Deletion" Accession="VCV000002076" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-17" DateCreated="2015-08-05" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17115" VariationID="2076">
      <GeneList>
        <Gene Symbol="GJC2" FullName="gap junction protein gamma 2" GeneID="57165" HGNC_ID="HGNC:17494" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="228149930" stop="228159826" display_start="228149930" display_stop="228159826" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="228337414" stop="228347526" display_start="228337414" display_stop="228347526" Strand="+" />
          </Location>
          <OMIM>608803</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020435.4(GJC2):c.914_947del (p.Pro305fs)</Name>
      <CanonicalSPDI>NC_000001.11:228158658:CGCCGCGGCCCCCCGGCCTCCGCCCCCGCCCCCGCGCCGCGGCCCCC:CGCCGCGGCCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="228158659" stop="228158692" display_start="228158659" display_stop="228158692" variantLength="34" positionVCF="228158658" referenceAlleleVCF="CCGCCGCGGCCCCCCGGCCTCCGCCCCCGCCCCCG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="228346360" stop="228346393" display_start="228346360" display_stop="228346393" variantLength="34" positionVCF="228346359" referenceAlleleVCF="CCGCCGCGGCCCCCCGGCCTCCGCCCCCGCCCCCG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P305fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.228346373_228346406del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.228346373_228346406del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.228158672_228158705del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.228158672_228158705del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011838.1" sequenceAccession="NG_011838" sequenceVersion="1" change="g.13821_13854del">
            <Expression>NG_011838.1:g.13821_13854del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020435.4" sequenceAccession="NM_020435" sequenceVersion="4" change="c.914_947del" MANESelect="true">
            <Expression>NM_020435.4:c.914_947del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065168.2" sequenceAccession="NP_065168" sequenceVersion="2" change="p.Pro305fs">
            <Expression>NP_065168.2:p.Pro305fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212786" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608803.0006" DB="OMIM" />
        <XRef Type="rs" ID="796065028" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 16969684 Fig. 3 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020435.4(GJC2):c.914_947del (p.Pro305fs) AND Hypomyelinating leukodystrophy 2" Accession="RCV000002157" Version="3">
        <ClassifiedConditionList TraitSetID="527">
          <ClassifiedCondition DB="MedGen" ID="C1837355">Hypomyelinating leukodystrophy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020435.4(GJC2):c.914_947del (p.Pro305fs) AND not provided" Accession="RCV001781168" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-08-05" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16969684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17031678</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="527" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5404" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PELIZAEUS-MERZBACHER-LIKE DISEASE, 1</ElementValue>
                <XRef Type="MIM" ID="608804" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 2</ElementValue>
                <XRef ID="MONDO:0012125" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD2</ElementValue>
                <XRef Type="MIM" ID="608804" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PMLD1</ElementValue>
                <XRef Type="MIM" ID="608804" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents during the neonatal or early-infantile period with nystagmus, commonly associated with hypotonia, delayed acquisition of motor milestones, speech delay, and dysarthria. Over time the hypotonia typically evolves into spasticity that affects the ability to walk and communicate. Cerebellar signs (gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia) frequently manifest during childhood. Some individuals develop extrapyramidal movement abnormalities (choreoathetosis and dystonia). Hearing loss and optic atrophy are observed in rare cases. Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis. Most individuals have normal cognitive skills or mild intellectual disability â€“ which, however, can be difficult to evaluate in the context of profound motor impairment.</Attribute>
                <XRef ID="NBK470716" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17293" />
                <XRef ID="17293" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29276893</ID>
                <ID Source="BookShelf">NBK470716</ID>
              </Citation>
              <XRef ID="280270" DB="Orphanet" />
              <XRef ID="280282" DB="Orphanet" />
              <XRef ID="C1837355" DB="MedGen" />
              <XRef ID="MONDO:0012125" DB="MONDO" />
              <XRef Type="MIM" ID="608804" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3965486" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="795f9e17b3d50698bf0432b6c6c8706b9660847809e7e2134afdf3a9d36b053a|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024275" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020435.4:c.914_947del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="22315" SubmissionDate="2015-08-03" DateLastUpdated="2015-08-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608803.0006_LEUKODYSTROPHY, HYPOMYELINATING, 2" title="GJC2, 34-BP DEL, NT914_LEUKODYSTROPHY, HYPOMYELINATING, 2" />
        <ClinVarAccession Accession="SCV000022315" DateUpdated="2015-08-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs, born of consanguineous Pakistani parents, with autosomal recessive hypomyelinating leukodystrophy (HLD2; 608804), Wolf et al. (2007) identified a homozygous 34-bp deletion in the GJA12 gene (del914-947), resulting in a frameshift and a truncated 154-residue peptide. Direct sequencing showed that the deletion was flanked by a 13-bp repeat sequence that may have contributed to formation of the deletion. The 2 sibs showed different clinical phenotypes. The older developed nystagmus at age 4 months, ataxia at 2 years, and spasticity at 6 years. The spasticity progressed, and she was wheelchair-bound by age 16 years. Her younger brother showed nystagmus at age 4 weeks as well as moderately impaired psychomotor development, and was never able to walk independently. He also had a severe sensory neuropathy, which may not have been related to the disorder. Both showed mainly dysmyelination in addition to progressive demyelination on brain MRI.</Attribute>
              <Citation>
                <ID Source="PubMed">16969684</ID>
              </Citation>
              <XRef DB="OMIM" ID="608804" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Salviati et al. (2007) reported the same homozygous 34-bp deletion (del914-947) in another affected Pakistani girl. Both unaffected parents carried the deletion and denied consanguinity. The deletion was not identified in 200 control alleles. Salviati et al. (2007) suggested a loss-of-function effect.</Attribute>
              <Citation>
                <ID Source="PubMed">17031678</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <Name>GJC2, 34-BP DEL, NT914</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">34-BP DEL, NT914</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608803.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LEUKODYSTROPHY, HYPOMYELINATING, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22315" TraitType="Disease" MappingType="Name" MappingValue="LEUKODYSTROPHY, HYPOMYELINATING, 2" MappingRef="Preferred">
        <MedGen CUI="C1837355" Name="Hypomyelinating leukodystrophy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3965486" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

